statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Exact Sciences Reports Q1 Loss, Joins Beyond Meat, Duolingo And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

Exact Sciences said first-quarter revenue increased 6% year-over-year to $638 million, which beat the consensus estimate of $627.355 million, according to Benzinga Pro. The company reported a...

Exact Sciences Stock Plunges On Q1 Earnings: What You Need To Know

Exact Sciences Stock, A Cathie Wood Darling, Tumbles On Wide Quarterly Losses...

Exact Sciences Stock, A Cathie Wood Darling, Tumbles On Wide Quarterly Losses

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company generated revenue of $638 million for the first quarter ended March...

Exact Sciences Announces First-Quarter 2024 Results

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, announced today the company will present six abstracts on strategies and advancements for improving...

Exact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW 2024

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited...

Exact Sciences to Participate in May Investor Conference

Exact Sciences (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, announced today the appointment of Aaron Bloomer as chief financial officer (CFO), effective May 15, 2024...

Exact Sciences Names Aaron Bloomer as New Chief Financial Officer

Exact Sciences Corp. (Nasdaq: EXAS) (the Company), a leading provider of cancer screening and diagnostic tests, today announced that on April 10, 2024 it entered into privately negotiated exchange...

Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, will present late-breaking data from the first analysis of the ASCEND-2 study demonstrating the...

Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to release its first quarter 2024 financial results after the...

Exact Sciences Schedules First Quarter 2024 Earnings Call

EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.

Watchers	10,965
52-Wk Low	$52.25
52-Wk High	$100.77

Volume	5.93M
52-Wk High	$100.77
52-Wk Low	$52.25

Period	Estimated	Reported	Surprise	Result
Q2'24	-$0.32	--	--	N/A
Q1'24	-$0.47	-$0.60	-26.32%	MISSED
Q4'23	-$0.42	-$0.27	36.16%	BEAT
Q3'23	-$0.47	$0.00	100.00%	BEAT
Q2'23	-$0.47	-$0.45	5.22%	BEAT

EXAS Exact Sciences Corp.

About

Feed

News

Sentiment

Earnings

Fundamentals